(BIOX) Bioceres Crop Solutions - Ratings and Ratios
Exchange: NASDAQ • Country: Argentina • Currency: USD • Type: Common Stock • ISIN: KYG1117K1141
BIOX: Seeds, Insecticides, Fungicides, Herbicides, Fertilizers, Inoculants
Bioceres Crop Solutions Corp (NASDAQ:BIOX), a leader in crop productivity solutions, operates through three core segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed segment offers seed traits and germplasms that enhance crop health and yield, while the Crop Protection segment provides essential chemicals like Rizoderma for pest control. The Crop Nutrition segment focuses on fertilizers and inoculants that promote soil health and nutrient uptake, benefiting sustainable agriculture.
The companys HB4 drought-tolerant technology is a standout innovation, aiding farmers in water-scarce regions. Founded in 2001 and based in Argentina, Bioceres has a strong presence in key agricultural markets worldwide. For more information, visit their investor site at https://investors.biocerescrops.com/home/default.a.
Looking ahead, the 3-month forecast suggests potential decline or consolidation due to the stock price being below major SMAs. Moderate volatility, indicated by an ATR of 0.37, may lead to price swings. However, if support holds, a bounce towards resistance levels is possible. Fundamentally, while the high P/E reflects current earnings, the lower forward P/E and attractive P/S ratio suggest undervaluation with growth potential, despite a low RoE. The companys strategic position in a growing agricultural sector and innovative technologies like HB4 position it well for future growth.
Additional Sources for BIOX Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
BIOX Stock Overview
Market Cap in USD | 250m |
Sector | Basic Materials |
Industry | Agricultural Inputs |
GiC Sub-Industry | Fertilizers & Agricultural Chemicals |
IPO / Inception | 2018-03-22 |
BIOX Stock Ratings
Growth Rating | -26.5 |
Fundamental | 24.4 |
Dividend Rating | 0.0 |
Rel. Strength | -63.4 |
Analysts | 5/5 |
Fair Price Momentum | 3.35 USD |
Fair Price DCF | 1.51 USD |
BIOX Dividends
No Dividends PaidBIOX Growth Ratios
Growth Correlation 3m | -78.3% |
Growth Correlation 12m | -95.6% |
Growth Correlation 5y | -4% |
CAGR 5y | -2.29% |
CAGR/Max DD 5y | -0.03 |
Sharpe Ratio 12m | -1.31 |
Alpha | -71.55 |
Beta | 0.475 |
Volatility | 79.40% |
Current Volume | 41.8k |
Average Volume 20d | 166.3k |
As of April 19, 2025, the stock is trading at USD 4.14 with a total of 41,767 shares traded.
Over the past week, the price has changed by -5.05%, over one month by -2.13%, over three months by -42.66% and over the past year by -66.15%.
Neither. Based on ValueRay Fundamental Analyses, Bioceres Crop Solutions is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 24.41 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BIOX as of April 2025 is 3.35. This means that BIOX is currently overvalued and has a potential downside of -19.08%.
Bioceres Crop Solutions has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy BIOX.
- Strong Buy: 4
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, BIOX Bioceres Crop Solutions will be worth about 3.6 in April 2026. The stock is currently trading at 4.14. This means that the stock has a potential downside of -12.8%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 7.9 | 90.3% |
Analysts Target Price | 12.1 | 193% |
ValueRay Target Price | 3.6 | -12.8% |